Clinical Trials
82 trialsMisterFIt
McGill University Health Centre/Research Institute of the McGill University Health Centre
DenosuMast
Assistance Publique - Hôpitaux de Paris
A Study of High-Dose Vit D Versus Standard of Care Vit D Supplementation
Wake Forest University Health Sciences
TEXT-Bone
ETOP IBCSG Partners Foundation
MoveStrong
University of Waterloo
HBHL
University of Nebraska
MoveStrong at Home: A Feasibility Study of a Model for Remote Delivery of Functional Strength and Balance Training Combined With Nutrition Education for Older Pre-frail Adults.
University of Waterloo
MAP3BSS
University Health Network, Toronto
Bone Mineral Density in Postmenopausal Women at Increased Risk of Breast Cancer And Who Are Receiving Exemestane on MAP3
Canadian Cancer Trials Group
Effect Of Whole Body Vibration Versus Weight Bearing Exercises On Osteoporosis In Breast Cancer Patients After Chemotherapy
Cairo University
PACEinMM-ON
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
PACEinMM-QC
Université de Sherbrooke
Sarcopenia and Risk of Falls in Patients With Major Chronic Diseases
Changhua Christian Hospital
Dried Plums Prevent Inflammation And Improve Bone Health in Osteopenic Men
Florida State University
EVOLVE
Alphatec Spine, Inc.
99Tc-MDP in Postmenopausal Women With Differentiated Thyroid Cancer and Osteoporosis
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
A Study of Actonel for the Prevention of Bone Loss
M.D. Anderson Cancer Center
Bone Markers and Bone Density Changes in Hyperperparathyroid Dialysis Patients Under Cinacalcet Treatment
Min-Sheng General Hospital
COMO-GMC
University of Aarhus
COAT
Shanghai Jiao Tong University School of Medicine
Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial
Canadian Cancer Trials Group
Bone Mineral Density and Subsequent Cancer Risk
National Institutes of Health Clinical Center (CC)
Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries
GOG Foundation
Zoledronate in Treating Osteopenia or Osteoporosis in Postmenopausal Women Receiving Letrozole for Stage I, Stage II, or Stage IIIA Primary Breast Cancer
Mayo Clinic
BREX
Finnish Breast Cancer Group
Changes in Knee Articular Cartilage Volume in Women on Aromatase Inhibitors
Monash University
Study to Compare the Efficacy and Safety of DenosumAb Versus Placebo in Males With Osteoporosis
Amgen
Prevention of Osteoporosis in Bone Marrow Transplantation (BMT) Patients
M.D. Anderson Cancer Center
STOPP-CIS
Children's Hospital of Eastern Ontario
Screening of Bone Mineral Density in Women Who Have Received Chemotherapy
Medical University of South Carolina
FREE Study - Fracture Reduction Evaluation
Medtronic Spinal and Biologics
Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy
Radiation Therapy Oncology Group
REBBeCA II
University of Pittsburgh
The Effect of Zoledronic Acid on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy
Novartis
Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss
Amgen
A Severity-Adapted Clinical Trial of Diminished Bone Mineral Density in Acute Lymphoblastic Leukemia Survivors
St. Jude Children's Research Hospital
EVOLVE
Medtronic Spinal and Biologics
Bone Health Management for Women Diagnosed With Breast Cancer
University of British Columbia
Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell Transplant
University of Minnesota
Study to Assess Efficacy and Safety of Zoledronic Acid and the Value of Markers of Bone Resorption in the Prediction of Bone Metastases and Cancer Treatment-induced Bone Loss (CTIBL) in Patients With Prostate Cancer on Hormone Therapy
Novartis
Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer
Alliance for Clinical Trials in Oncology
Zoledronate in Preventing Bone Loss in Postmenopausal Women Who Are Receiving Letrozole for Stage I, Stage II, or Stage IIIA Breast Cancer
Alliance for Clinical Trials in Oncology
Evaluation of PET/MR and PET/CT Imaging for Bone Marrow Lesions
NYU Langone Health
Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer
Alliance for Clinical Trials in Oncology
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
Alliance for Clinical Trials in Oncology
Understanding and Discouraging Overuse of Potentially Harmful Screening Tests
University of North Carolina, Chapel Hill
Women's Health Initiative (WHI)
National Heart, Lung, and Blood Institute (NHLBI)
Study to Determine the Prevalence of Osteoporosis in Patients With Advanced Prostate Cancer Treated With Hormonal Manipulation
AHS Cancer Control Alberta
One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation Study
University of Pittsburgh
Exercise for Physical Health in Men With Prostate Cancer
OHSU Knight Cancer Institute